Visgeneer (4197) - Total Liabilities

Latest as of December 2025: NT$135.94 Million TWD ≈ $4.28 Million USD

Based on the latest financial reports, Visgeneer (4197) has total liabilities worth NT$135.94 Million TWD (≈ $4.28 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore 4197 year-over-year net asset growth to track the company's year-over-year net asset growth rate.

Visgeneer - Total Liabilities Trend (2011–2025)

This chart illustrates how Visgeneer's total liabilities have evolved over time, based on quarterly financial data. See Visgeneer free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.

Visgeneer Competitors by Total Liabilities

The table below lists competitors of Visgeneer ranked by their total liabilities.

Company	Country	Total Liabilities
EA Holdings Bhd KLSE:0154	Malaysia	RM5.99 Million
Scandinavian ChemoTech AB Series B ST:CMOTEC-B	Sweden	Skr9.47 Million
HYDROGEN UTOPIA INT.-001 F:D60	Germany	€1.06 Million
Nyrstar NV BR:NYR	Belgium	€20.26 Million
Intanwijaya Internasional Tbk JK:INCI	Indonesia	Rp73.38 Billion
Synaptogenix Inc NASDAQ:SNPX	USA	$1.83 Million
Bitros Holding S.A AT:MPITR	Greece	€163.83 Million

Liability Composition Analysis (2011–2025)

This chart breaks down Visgeneer's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Visgeneer.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	3.69	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.68	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.41	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Visgeneer's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Visgeneer (2011–2025)

The table below shows the annual total liabilities of Visgeneer from 2011 to 2025.

Year	Total Liabilities	Change
2025-12-31	NT$135.94 Million ≈ $4.28 Million	-1.67%
2024-12-31	NT$138.25 Million ≈ $4.36 Million	-25.51%
2023-12-31	NT$185.60 Million ≈ $5.85 Million	-27.38%
2022-12-31	NT$255.58 Million ≈ $8.05 Million	+22.74%
2021-12-31	NT$208.23 Million ≈ $6.56 Million	-14.65%
2020-12-31	NT$243.97 Million ≈ $7.69 Million	-7.37%
2019-12-31	NT$263.37 Million ≈ $8.30 Million	+30.32%
2018-12-31	NT$202.09 Million ≈ $6.37 Million	-24.20%
2017-12-31	NT$266.61 Million ≈ $8.40 Million	+28.32%
2016-12-31	NT$207.76 Million ≈ $6.55 Million	-7.10%
2015-12-31	NT$223.64 Million ≈ $7.05 Million	+218.59%
2014-12-31	NT$70.20 Million ≈ $2.21 Million	+50.02%
2013-12-31	NT$46.79 Million ≈ $1.47 Million	+45.00%
2012-12-31	NT$32.27 Million ≈ $1.02 Million	+21.13%
2011-12-31	NT$26.64 Million ≈ $839.34K	--

About Visgeneer

TWO:4197 Taiwan Biotechnology

Market Cap

$8.09 Million

NT$256.84 Million TWD

Market Cap Rank

#27554 Global

#1587 in Taiwan

Share Price

NT$8.51

Change (1 day)

+0.47%

52-Week Range

NT$8.20 - NT$19.00

All Time High

NT$28.80